CELLFLUIDX LTD
B68/100Summary
CELLFLUIDX LTD is an active private limited company (company number 12866927) incorporated on 9 September 2020, registered in Newcastle Upon Tyne. Its registered activity is manufacture of medical and dental instruments and supplies (SIC 32500). Latest micro accounts cover the period ending 30 September 2025, showing net assets of £2,092, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 22% on the prior period (£1,721).
By net assets it sits in the lower half of 1,751 comparable companies in the UK (median £3,916, upper quartile £88k).
Key dates
- Incorporated
- 9 September 20206 yrs ago
- Next accounts due
- 30 June 2027in 251 days
- Confirmation statement due
- 23 September 2027in 336 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 32500
- Manufacture of medical and dental instruments and supplies
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £2,092 | — | — | £2,093 | — | — | 1 |
| 30 September 2024 | £1,721 | — | — | £1,722 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £2,092 at 2025-09-30 |
| +8 | Net assets growing+21.6% vs prior period |
| −8 | Current liabilities exceed current assetsCurrent ratio 0.0 |
| +8 | EstablishedIncorporated 2020-09-09 (6 years) |
| 68 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
Ownership and control
- Dr. Majid Arefi
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Jonathan James O'Halloran
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Confirmation statement duein 336 days
- Next accounts duein 251 days
- Accounts period endNet assets £2,092 · micro accounts
- Accounts period endNet assets £1,721 · micro accounts
- Incorporated
Similar companies in Newcastle
- INDICIA DEVICES LIMITEDNewbiggin-By-The-Sea · inc. Mar 2021
- LPD NORTH EAST LIMITEDNorth Shields · inc. Nov 2019
- SMILE WIDE LTDNorth Shields · inc. Dec 2021
- MANGO DENTAL TECHNOLOGIES LIMITEDGateshead · inc. Mar 2022
- WESCOTT MEDICAL (DISTRIBUTORS) LIMITEDWashington · inc. Apr 2022
- 3D BIO-TISSUES LIMITEDNewcastle Upon Tyne · inc. Nov 2018
All companies incorporated on 9 September 2020 · in Sept 2020.
Reminders for CELLFLUIDX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.